{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Tonawanda",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "72629",
      "recalling_firm": "Pine Pharmaceuticals, LLC",
      "address_1": "100 Colvin Woods Pkwy Suite 300",
      "address_2": "N/A",
      "postal_code": "14150-6974",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-0584-2016",
      "product_description": "Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16\" Syringe for intravitreal injection, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.",
      "product_quantity": "N/A",
      "reason_for_recall": "Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.",
      "recall_initiation_date": "20151104",
      "center_classification_date": "20160120",
      "termination_date": "20170322",
      "report_date": "20160127",
      "code_info": "Lot #: 1918@5, exp. 1/26/2016; 1820@5, exp. 1/12/2016; 1773@5, exp. 1/6/2016; 1665@5, exp. 12/22/2015; 1542@5, exp. 12/1/2015; 1544@6, exp. 12/1/2015.",
      "more_code_info": ""
    }
  ]
}